Citations

Showing 10 of 108081 citations.

Cellular functions of WASP family proteins at a glance
Alekhina, Olga , Billadeau, Daniel D. , Billadeau, Daniel D , Burstein, Ezra

Mayo Clinic

Journal of Cell Science | June 23, 2017 | Volume: 130 | Issue: 14 | Pages: 2235-2241

10.1242/jcs.199570 | PMID 28646090 Get It

ABSTRACT Proteins of the Wiskott–Aldrich syndrome protein (WASP) family function as nucleation-promoting factors for the ubiquitously expressed Arp2/3 complex, which drives the generation of branched actin filaments. Arp2/3-generated actin regulates diverse cellular processes, including the formation of lamellipodia and filopodia, endocytosis and/or phagocytosis at the plasma membrane, and the generation of cargo-laden vesicles from organelles including the Golgi, endoplasmic reticulum (ER) and the endo-lysosomal network. Recent studies have also identified roles for WASP family members in promoting actin dynamics at the centrosome, influencing nuclear shape and membrane remodeling events leading to the generation of autophagosomes. Interestingly, several WASP family members have also been observed in the nucleus where they directly influence gene expression by serving as molecular platforms for the assembly of epigenetic and transcriptional machinery. In this Cell Science at a Glance article and accompanying poster, we provide an update on the subcellular roles of WHAMM, JMY and WASH (also known as WASHC1), as well as their mechanisms of regulation and emerging functions within the cell.
Gastrointestinal: Zollinger–Ellison Syndrome: A rare cause of chronic diarrhea and abdominal pain
Anderson, Bradley J. , Sweetser, Seth

Mayo Clinic

Journal of Gastroenterology and Hepatology | June 23, 2017 | Volume: 32 | Issue: 7 | Pages: 1281-1281

10.1111/jgh.13630 | PMID 28639271 Get It

Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Oursler, Merry Jo, Drake, Matthew T. , Clarke, Bart L, Clarke, B.L. , Khosla, Sundeep

Mayo Clinic

Endocrine Reviews | June 23, 2017 | Volume: 38 | Issue: 4 | Pages: 325-350

10.1210/er.2015-1114 | PMID 28651365 Get It

Thirty-day postoperative morbidity and mortality after temporal lobectomy for medically refractory epilepsy
Kerezoudis, Panagiotis , McCutcheon, Brandon A., Murphy, Meghan E. , Rajjoub, Kenan , Ubl, Daniel S. , Habermann, Elizabeth B. , Bydon, Mohamad , McCutcheon, Brandon, Ubl, Daniel, Worrell, Gregory A. , Gompel, Jamie J. Van , Habermann, Elizabeth

Mayo Clinic

Journal of Neurosurgery | June 23, 2017 | Volume: 128 | Issue: 4 | Pages: 1158-1164

10.3171/2016.12.jns162096 | PMID 28644097 Get It

OBJECTIVETemporal lobectomy is a well-established treatment modality for the management of medically refractory epilepsy in appropriately selected patients. The aim of this study was to assess 30-day morbidity and mortality after temporal lobectomy in cases registered in a national database.METHODSA retrospective cohort analysis was conducted using a multiinstitutional surgical registry compiled between 2006 and 2014. The authors identified patients who underwent anterior temporal lobectomy and/or amygdalohippocampectomy for a primary diagnosis of intractable epilepsy. Univariate and multivariable analyses with regard to patient demographics, comorbidities, operative characteristics, and 30-day outcomes were applied.RESULTSA total of 216 patients were included in the study. The median age was 38 years and 46% of patients were male. The median length of stay was 3 days and the 30-day mortality rate was 1.4%. Fourteen patients (6.5%) developed at least one major complication. Return to the operating room was observed in 7 patients (3.2%). Readmission within 30 days and discharge to a location other than home were available for 2011–2014 (n = 155) and occurred in 11% and 10.3% of patients, respectively. Multivariable regression analysis revealed that increasing age was an independent predictor of discharge disposition other than home and that male sex was a significant risk factor for the development of a major complication. Interestingly, the presence of the attending neurosurgeon and a resident during the procedure was significantly associated with decreased odds of prolonged length of stay (i.e., > 75th percentile [5 days]) and discharge to a location other than home.CONCLUSIONSUsing a multiinstitutional surgical registry, 30-day outcome data after temporal lobectomy for medically intractable epilepsy demonstrates a mortality rate of 1.4%, a major complication rate of 6.5%, and a readmission rate of 11%. Temporal lobectomy is an extremely effective therapy for seizures originating there—however, surgical intervention must be weighed against its morbidity and mortality outcomes.
Young Athletes After Anterior Cruciate Ligament Reconstruction With Single-Leg Landing Asymmetries at the Time of Return to Sport Demonstrate Decreased Knee Function 2 Years Later
Ithurburn, Matthew P. , Paterno, Mark V. , Ford, Kevin R. , Hewett, Timothy E. , Schmitt, Laura C.

Mayo Clinic

The American Journal of Sports Medicine | June 23, 2017 | Volume: 45 | Issue: 11 | Pages: 2604-2613

10.1177/0363546517708996 | PMID 28644677 Get It

Background: Previous work shows that young athletes after anterior cruciate ligament reconstruction (ACLR) demonstrate single-leg (SL) landing movement asymmetries at the time of return to sport (RTS); however, the effect of movement asymmetries on longitudinal knee-related function after ACLR has not been examined. Hypothesis/Purpose: The purpose of this study was to examine the effect of SL drop-landing movement symmetry at the time of RTS on knee-related function 2 years later in young athletes after ACLR. The first hypothesis was that young athletes who demonstrated SL drop-landing asymmetries at RTS would demonstrate decreased knee function 2 years later compared with those who demonstrated symmetric SL drop-landing mechanics. The second hypothesis was that SL drop-landing movement symmetry at RTS would be associated with knee functional recovery 2 years later. Study Design: Cohort study; Level of evidence, 2. Methods: This study included 48 young athletes who had undergone ACLR and were assessed at the time of RTS (77% female; mean [±SD] age at RTS, 17.6 ± 2.6 years) and followed for 2 years after RTS. Three sagittal-plane landing variables of interest were calculated using 3-dimensional motion analysis during an SL drop-landing task at the time of RTS: knee flexion excursion, peak internal knee extension moment, and peak trunk flexion. The limb symmetry index (LSI) was calculated for each landing variable using the following: LSI = (involved/uninvolved) × 100%. The LSI was used to divide the cohort into symmetric (SYM) and asymmetric (ASYM) groups for each landing variable: knee flexion excursion (SYM: LSI ≥ 90% [n = 23]; ASYM: LSI < 85% [n = 18]), peak internal knee extension moment (SYM: LSI ≥ 90% [n = 19]; ASYM: LSI < 85% [n = 22]), and peak trunk flexion (SYM: LSI ≤ 105% [n = 25]; ASYM: LSI > 115% [n = 19]). At 2 years after RTS, knee-related function was evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) subjective knee form, and performance on SL hop tests. Functional recovery was defined based on literature cutoffs for knee-related functional measures. Differences in 2-year function were compared between the symmetry groups using Mann-Whitney U tests because of nonnormality. Logistic regression was used to determine if landing symmetry at the time of RTS would be associated with 2-year knee functional recovery after RTS. Results: The ASYM knee flexion excursion group demonstrated decreased function at 2 years after RTS compared with the SYM group on the KOOS-Pain (ASYM: 93.0 ± 8.2; SYM: 98.4 ± 3.0; P = .008) and the KOOS–Quality of Life (ASYM: 81.6 ± 16.1; SYM: 94.1 ± 9.7; P = .008). Knee flexion excursion was associated with knee functional recovery on the KOOS-Pain and the KOOS–Quality of Life ( P = .033 and P = .012, respectively) at 2 years after RTS, after controlling for the quadriceps strength LSI and graft type. Conclusion: Young athletes after ACLR with asymmetries in knee kinematics at the time of RTS reported decreased self-reported function 2 years later; however, the clinical importance of these differences needs to be further understood.
ECG-based 4D-dose reconstruction of cardiac arrhythmia ablation with carbon ion beams: application in a porcine model
Eichhorn, Anna, Constantinescu, A., Kaderka, Robert, Prall, Matthias, Lugenbiel, Patrick , Takami, Mitsuru , Thomas, Dierk , Bert, Christoph , Packer, Douglas L. , Graeff, Christian , Lehmann, H. Immo , Bert, Christoph , Durante, Marco , Graeff, Christian , Richter, Daniel , Prall, M. W., Durante, Marco

Mayo Clinic

Physics in Medicine & Biology | June 23, 2017 | Volume: 62 | Issue: 17 | Pages: 6869-6883

10.1088/1361-6560/aa7b67 | PMID 28644151 Get It

Abstract Noninvasive ablation of cardiac arrhythmia by scanned particle radiotherapy is highly promising, but especially challenging due to cardiac and respiratory motion. Irradiations for catheter-free ablation in intact pigs were carried out at the GSI Helmholtz Center in Darmstadt using scanned carbon ions. Here, we present real-time electrocardiogram (ECG) data to estimate time-resolved (4D) delivered dose. For 11 animals, surface ECGs and temporal structure of beam delivery were acquired during irradiation. R waves were automatically detected from surface ECGs. Pre-treatment ECG-triggered 4D-CT phases were synchronized to the R – R interval. 4D-dose calculation was performed using GSI’s in-house 4D treatment planning system. Resulting dose distributions were assessed with respect to coverage ( D 95 and V 95), heterogeneity (HI = D 5– D 95) and normal tissue exposure. Final results shown here were performed offline, but first calculations were started shortly after irradiation The D 95 for TV and PTV was above 95% for 10 and 8 out of 11 animals, respectively. HI was reduced for PTV versus TV volumes, especially for some of the animals targeted at the atrioventricular junction, indicating residual interplay effects due to cardiac motion. Risk structure exposure was comparable to static and 4D treatment planning simulations. ECG-based 4D-dose reconstruction is technically feasible in a patient treatment-like setting. Further development of the presented approach, such as real-time dose calculation, may contribute to safe, successful treatments using scanned ion beams for cardiac arrhythmia ablation.
Faculty Opinions recommendation of Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Kaufmann, Scott H. , Yun, Seongseok

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 23, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727620770.793533377 Get It

Low leptin concentration may identify heart failure patients with central sleep apnea
Čundrle, Ivan , Singh, Prachi , Johnson, Bruce D. , Olson, Lyle J. , Olson, Lyle J , Somers, Virend K. , Scott, Christopher G. , Singh, Prachi , Cundrle, Ivan

Mayo Clinic

Journal of Sleep Research | June 23, 2017 | Volume: 27 | Issue: 2 | Pages: 240-243

10.1111/jsr.12574 | PMID 28643476 Get It

SummaryLow leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I–IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea–hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty‐six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL−1 versus 19.7 ± 14.7 ng mL−1, P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL−1 versus 17.1 ± 8.4 ng mL−1, P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06–0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut‐off value for leptin concentration 5 ng mL−1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
A Neuropsychiatric Analysis of the Cotard Delusion
Sahoo, Aradhana, Josephs, Keith A.

Mayo Clinic

The Journal of Neuropsychiatry and Clinical Neurosciences | June 23, 2017 | Volume: 30 | Issue: 1 | Pages: 58-65

10.1176/appi.neuropsych.17010018 | PMID 28641497 Get It